Newleaf Healthcare

Boldenan-400 (Boldenone Undecylenate 400 mg/ml, 10 ml) is a concentrated injectable anabolic-androgenic steroid (AAS) formulation containing boldenone undecylenate as its active ingredient. Boldenone is a synthetic derivative of testosterone that was originally developed for veterinary applications, particularly to improve muscle mass, appetite, and overall condition in livestock and horses. It is not approved for human therapeutic use in many countries, and non-medical use for bodybuilding or athletic performance enhancement can pose serious health risks.

Boldenone undecylenate works by binding to androgen receptors in muscle tissue, stimulating protein synthesis and increasing nitrogen retention in the body. Nitrogen is a critical component of muscle tissue, and maintaining a positive nitrogen balance supports muscle growth and recovery. Due to the undecylenate ester attached to the hormone, Boldenan-400 provides a slow and sustained release into the bloodstream after intramuscular injection. The 400 mg/ml concentration makes it a high-strength preparation intended for veterinary administration under professional supervision.

One of the notable properties of boldenone is its ability to promote steady, gradual gains in lean muscle mass rather than rapid weight increase. It may also stimulate erythropoiesis, leading to increased red blood cell production. While this can enhance oxygen delivery to tissues, excessive red blood cell production may thicken the blood and increase the risk of cardiovascular complications if not properly monitored.

Despite its anabolic benefits, boldenone undecylenate carries potential side effects. Androgenic effects may include acne, oily skin, increased body hair growth, and hair loss in individuals predisposed to male pattern baldness. In women, virilization symptoms such as voice deepening and menstrual irregularities may occur. Boldenone can suppress natural testosterone production in men, potentially leading to hormonal imbalance, reduced fertility, and testicular atrophy with prolonged use.

Estrogen-related side effects, such as water retention or gynecomastia (development of breast tissue in men), may also occur due to partial conversion of boldenone to estrogen. Additionally, anabolic steroid misuse can negatively affect cholesterol levels by decreasing HDL (good cholesterol) and increasing LDL (bad cholesterol), thereby raising the risk of heart disease. Long-term use may also place strain on the liver and kidneys.

Psychological effects such as mood swings, irritability, or increased aggression have been reported with anabolic steroid use. Because boldenone is not approved for human medical treatment, its safety and efficacy in humans have not been fully established through clinical trials.

Boldenan-400 injection should only be used for approved veterinary purposes under proper supervision. The non-medical use of anabolic steroids may lead to serious health complications and legal consequences in many regions.

In conclusion, Boldenan-400 (Boldenone Undecylenate 400 mg/ml) is a high-potency veterinary anabolic steroid intended for animal use. While known for promoting muscle development and improved condition, misuse carries significant health and safety risks.

Mixtren 200 is an injectable blend of three powerful anabolic steroids (trenbolone acetate, trenbolone enanthate, and trenbolone hexahydrobenzylcarbonate) that was originally developed for veterinary use to promote muscle growth and feed efficiency in livestock (cattle). 

Nandrolone Decanoate Injection (100mg) (Duradec-100)(Deca Durabolin Injection) Deca-Durabolin 50 Injection is a medicine used in the treatment of osteoporosis in post-menopausal women. It helps strengthen the bones which become thin and brittle due to osteoporosis.

it is used to treat conditions such as arthritis, blood problems, immune system disorders, skin and eye conditions, breathing problems, cancer

Cypiomax 250 mg/ml (British Pharma) is an injectable anabolic-androgenic steroid (AAS) designed for intramuscular injection, containing 250 mg of Testosterone Cypionate per 1 mL of solution in a 10 mL vial. It is widely used for hormone replacement therapy in men and for bodybuilding purposes to promote muscle growth and strength. IndiaMART +3Key Product Details

• Active Ingredient & Strength: 250 mg/mL Testosterone Cypionate.
• Manufacturer: British Pharma.
• Presentation: 10 mL vial for intramuscular injection.
• Characteristics: A long-acting ester of testosterone designed for a slow, sustained release. 

Ondican 4 Injection 4 ml contains Ondansetron that blocks the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting caused by chemotherapy in adults and children and also after surgery.

Noveltreat 0.25 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 0.25 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 0.25 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 0.25 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 0.25 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 0.25 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 0.25 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Noveltreat 2.4 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 2.4 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 2.4 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 2.4 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 2.4 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 2.4 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 2.4 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.